Sanofi con­tin­ues mR­NA push in wake of Covid vac­cine set­back, part­ner­ing with Chi­na tech gi­ant Baidu

Back in June, Sanofi un­veiled a big project to re­shape its R&D around the fu­ture of mR­NA, and fol­lowed that up Mon­day by tak­ing a step to­ward achiev­ing that goal.

The French drug­mak­er signed a deal with Chi­nese tech gi­ant Baidu to ac­cess its AI al­go­rithm for mR­NA-based ther­a­peu­tics, Baidu said Mon­day morn­ing. It’s for an undis­closed sum, but Baidu not­ed its plat­forms will be used to “con­tribute to the op­ti­miza­tion of mR­NA se­quences” in Sanofi’s drug de­vel­op­ment process­es.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN